These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 9694074)
1. Protection of CCRF-CEM human lymphoid cells from antifolates by retroviral gene transfer of variants of murine dihydrofolate reductase. Mareya SM; Sorrentino BP; Blakley RL Cancer Gene Ther; 1998; 5(4):225-35. PubMed ID: 9694074 [TBL] [Abstract][Full Text] [Related]
2. Retroviral vectors containing a variant dihydrofolate reductase gene for drug protection and in vivo selection of hematopoietic cells. Allay JA; Galipeau J; Blakley RL; Sorrentino BP Stem Cells; 1998; 16 Suppl 1():223-33. PubMed ID: 11012166 [TBL] [Abstract][Full Text] [Related]
3. Retroviral coexpression of thymidylate synthase and dihydrofolate reductase confers fluoropyrimidine and antifolate resistance. Fantz CR; Shaw D; Moore JG; Spencer HT Biochem Biophys Res Commun; 1998 Feb; 243(1):6-12. PubMed ID: 9473470 [TBL] [Abstract][Full Text] [Related]
4. Increased resistance to nitrogen mustards and antifolates following in vitro selection of murine fibroblasts and primary hematopoietic cells transduced with a bicistronic retroviral vector expressing the rat glutathione S-transferase A3 and a mutant dihydrofolate reductase. Belzile JP; Karatzas A; Shiu HY; Létourneau S; Palerme JS; Cournoyer D Cancer Gene Ther; 2003 Aug; 10(8):637-46. PubMed ID: 12872145 [TBL] [Abstract][Full Text] [Related]
6. Patterns of cross-resistance to the antifolate drugs trimetrexate, metoprine, homofolate, and CB3717 in human lymphoma and osteosarcoma cells resistant to methotrexate. Diddens H; Niethammer D; Jackson RC Cancer Res; 1983 Nov; 43(11):5286-92. PubMed ID: 6225514 [TBL] [Abstract][Full Text] [Related]
7. Generation of dual resistance to 4-hydroperoxycyclophosphamide and methotrexate by retroviral transfer of the human aldehyde dehydrogenase class 1 gene and a mutated dihydrofolate reductase gene. Takebe N; Zhao SC; Adhikari D; Mineishi S; Sadelain M; Hilton J; Colvin M; Banerjee D; Bertino JR Mol Ther; 2001 Jan; 3(1):88-96. PubMed ID: 11162315 [TBL] [Abstract][Full Text] [Related]
9. Selective expression of methotrexate-resistant dihydrofolate reductase (DHFR) activity in mice transduced with DHFR retrovirus and administered methotrexate. Vinh DB; McIvor RS J Pharmacol Exp Ther; 1993 Nov; 267(2):989-96. PubMed ID: 8246174 [TBL] [Abstract][Full Text] [Related]
10. Cells exposed to antifolates show increased cellular levels of proteins fused to dihydrofolate reductase: a method to modulate gene expression. Mayer-Kuckuk P; Banerjee D; Malhotra S; Doubrovin M; Iwamoto M; Akhurst T; Balatoni J; Bornmann W; Finn R; Larson S; Fong Y; Gelovani Tjuvajev J; Blasberg R; Bertino JR Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3400-5. PubMed ID: 11891321 [TBL] [Abstract][Full Text] [Related]
11. Transgenic mice expressing the tyr22 variant of murine DHFR: protection of transgenic marrow transplant recipients from lethal doses of methotrexate. James RI; May C; Vagt MD; Studebaker R; McIvor RS Exp Hematol; 1997 Nov; 25(12):1286-95. PubMed ID: 9357973 [TBL] [Abstract][Full Text] [Related]
12. In vitro mutations in dihydrofolate reductase that confer resistance to methotrexate: potential for clinical application. Blakley RL; Sorrentino BP Hum Mutat; 1998; 11(4):259-63. PubMed ID: 9554740 [TBL] [Abstract][Full Text] [Related]
13. Protection of hematopoietic stem cells from pemetrexed toxicity by retroviral gene transfer with a mutant dihydrofolate reductase-mutant thymidylate synthase fusion gene. Capiaux GM; Budak-Alpdogan T; Alpdogan O; Bornmann W; Takebe N; Banerjee D; Maley F; Bertino JR Cancer Gene Ther; 2004 Dec; 11(12):767-73. PubMed ID: 15359285 [TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of resistance to antifolates, a review. Banerjee D; Ercikan-Abali E; Waltham M; Schnieders B; Hochhauser D; Li WW; Fan J; Gorlick R; Goker E; Bertino JR Acta Biochim Pol; 1995; 42(4):457-64. PubMed ID: 8852336 [TBL] [Abstract][Full Text] [Related]
15. Cancer research: from folate antagonism to molecular targets. Bertino JR Best Pract Res Clin Haematol; 2009 Dec; 22(4):577-82. PubMed ID: 19959110 [TBL] [Abstract][Full Text] [Related]
16. Selection for methotrexate resistance in mammalian cells bearing a Drosophila dihydrofolate reductase transgene: Methotrexate resistance in transgenic mammalian cells. Affleck JG; Nowickyj SM; Walker VK Cell Biol Toxicol; 2010 Apr; 26(2):117-26. PubMed ID: 19337845 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the protection of cells from antifolates by transduced human dihydrofolate reductase mutants. Patel M; Sleep SE; Lewis WS; Spencer HT; Mareya SM; Sorrentino BP; Blakley RL Hum Gene Ther; 1997 Nov; 8(17):2069-77. PubMed ID: 9414255 [TBL] [Abstract][Full Text] [Related]
18. Methotrexate selection of long-term culture initiating cells following transduction of CD34(+) cells with a retrovirus containing a mutated human dihydrofolate reductase gene. Takebe N; Xu LC; MacKenzie KL; Bertino JR; Moore MA Cancer Gene Ther; 2002 Mar; 9(3):308-20. PubMed ID: 11896448 [TBL] [Abstract][Full Text] [Related]
19. Comparison of methotrexate resistance conferred by a mutated dihydrofolate reductase (DHFR) cDNA in two different retroviral vectors. Takebe N; Nakahara S; Zhao SC; Adhikari D; Ural AU; Iwamoto M; Banerjee D; Bertino JR Cancer Gene Ther; 2000 Jun; 7(6):910-9. PubMed ID: 10880023 [TBL] [Abstract][Full Text] [Related]
20. Mutations leading to antifolate resistance in Chinese hamster ovary cells after exposure to the alkylating agent ethylmethanesulfonate. Fanin R; Banerjee D; Volkenandt M; Waltham M; Li WW; Dicker AP; Schweitzer BI; Bertino JR Mol Pharmacol; 1993 Jul; 44(1):13-21. PubMed ID: 8341268 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]